NGL FINE-CHEM LTD.

NGL Fine Chem Ltd has announced the commencement of commercial production for Phase II of its Greenfield facility located in Tarapur, Maharashtra, effective September 24, 2026. This expansion is part of the company's strategy to augment its manufacturing infrastructure and meet the demands of its diverse active pharmaceutical ingredients (API) product portfolio. Phase I of the facility had previously commenced production on March 11, 2025. The company notes that aggregate installed capacity cannot be expressed as a single uniform quantity due to varying product mixes and API manufacturing processes, emphasizing flexible utilization. The total investment in the Greenfield expansion facility up to the commencement date is approximately ₹222 crore, financed through a combination of term loans from banks (₹84 crore) and internal accruals (₹138 crore). The facility is now fully commissioned and operational.

NGL Fine Chem Ltd has issued a corrigendum to its 45th Annual Report for FY 2025-26. The company identified a typographical error on page 26, specifically in the non-statutory 'Corporate Social Responsibility' section. Certain CSR amounts were incorrectly stated as 'Crores' instead of 'Lakhs'. The correction impacts CSR spend in FY26 from ₹41.50 Crores to ₹41.50 Lakhs and the Statutory CSR Obligation from ₹51.61 Crores to ₹51.61 Lakhs. This error does not affect the company's financial statements for the year ended March 31, 2026. The updated Annual Report is available on the company's website.

NGL Fine Chem Ltd has been fined a total of ₹23,600 by BSE Limited and the National Stock Exchange of India Limited for delays in complying with Regulation 29(2)/29(3) of SEBI Listing Regulations. The fines, amounting to ₹11,800 from each exchange, have been paid by the company. The Board of Directors acknowledged the inadvertent procedural delay and has strengthened internal compliance monitoring to ensure timely adherence to regulations going forward. Management has been advised to exercise due diligence and strict adherence to prescribed timelines.

NGL Fine Chem Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The results, which were standalone and consolidated, were approved by the Board of Directors on August 12, 2026. The company has submitted these results along with a limited review report from its statutory auditors, Manek & Associates. The review confirmed that the financial statements are prepared in accordance with Indian Accounting Standard 34 and comply with SEBI regulations, with no material misstatements identified.

NGL Fine Chem Ltd announced that its Board of Directors met on August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The results were prepared on a standalone and consolidated basis, in accordance with Indian Accounting Standard 34 (IND AS 34) and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's statutory auditors have provided a limited review report on these unaudited financial statements. The board meeting commenced at 4:50 p.m. and concluded at 5:20 p.m.

NGL Fine-Chem Limited has submitted its Annual Report for the Financial Year 2025-26, along with the notice for its 45th Annual General Meeting (AGM) scheduled for August 25, 2026. The report highlights a significant recovery in FY26, with revenue from operations increasing by 36% to ₹500.95 crores. EBITDA more than doubled to ₹72.69 crores, and profit after tax grew by 128% to ₹48.13 crores. This growth was driven by increased volumes, improved capacity utilization, and disciplined cost management. The company is focusing on expanding into regulated markets and has advanced its CEP, ASMF, and VMF pipelines. Phase I of the greenfield expansion at Tarapur is operational, with Phase II expected to support commercial production from the second half of FY27.

NGL Fine-Chem Limited has submitted its Business Responsibility and Sustainability Reporting (BRSR) for the financial year 2025-26, in compliance with SEBI (LODR) Regulations, 2015. The report, which forms part of the Integrated Annual Report, details the company's commitment to integrating Environmental, Social, and Governance (ESG) principles into its core strategy. NGL Fine-Chem emphasizes sustainable operations for enduring enterprise value, focusing on environmental stewardship, social capital, and robust governance. The company manufactures pharmaceuticals and intermediates for veterinary and human health, with 100% of its turnover derived from this activity. Operations are primarily domestic, with a significant international market presence across 54 countries.

NGL Fine-Chem Limited has submitted the Notice for its 45th Annual General Meeting (AGM) and the Annual Report for the Financial Year 2025-26. The AGM is scheduled for August 25, 2026, to be held via Video Conferencing. The company reported a strong financial performance for FY26, with revenue increasing by 36% to ₹500.95 crores, EBITDA more than doubling to ₹72.69 crores, and profit after tax growing by 128% to ₹48.13 crores. This recovery was driven by volume growth, improved capacity utilization, and cost management. The company is focused on its 'Building for the Next Phase of Growth' strategy, with ongoing greenfield expansion at Tarapur and advancements in regulated markets, including CEP, ASMF, and VMF pipelines. The report highlights investments in manufacturing, R&D, and global presence, positioning NGL Fine-Chem for sustained long-term value creation.

NGL Fine Chem Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from Wednesday, July 1, 2026, and will remain in effect until 48 hours after the declaration of the company's unaudited financial results for the quarter ended June 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct to prevent insider trading. The date of the board meeting to consider these financial results will be communicated separately.

NGL Fine Chem Ltd's board approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹1.75 per share. The 45th Annual General Meeting (AGM) will be held on August 25, 2026, via video conferencing. The record date for the AGM and dividend payment is August 18, 2026, with the register of members and share transfer books closed from August 19-25, 2026.